OCENA KARDIOTOKSYCZNOŚCI TRASTUZUMABU W LECZENIU ADJUWANTOWYM CHORYCH NA HER2 POZYTYWNEGO RAKA PIERSI

Abstract

Author(s): E Staroslawska, A CzerepiÅ?ska, A Chrzanowska-Kapica, A Twardosz Centrum Onkologii Ziemi Lubelskiej, Lublin

OCENA KARDIOTOKSYCZNOŚCI TRASTUZUMABU W LECZENIU ADJUWANTOWYM CHORYCH NA HER2 POZYTYWNEGO RAKA PIERSI

Share this article

Editors List

  • S.SREEDHAR

    Submitted PhD thesis in Biotechnology at GITAM University, Vizag.

  • Yousef Alomi

    Yousef Alomi
    The Past Head, General Administration of Pharmaceutical Care at Ministry of Health,
    Saudi Arabia Critical Care/TPN
    Clinical Pharmacist Ministry of Health,
    Riyadh, Saudi Arabia.

  • Osamu Tanaka

    Osamu Tanaka
    Assistant Professor,
    Department of Radiation Oncology
    Asahi University Hospital
    Gifu city, Gifu, Japan

  • Maher Abdel Fattah Al-Shayeb

    Department of Surgical Sciences, Ajman University, UAE

  • Andrzej Zdziennicki

    Institute of Gynecology and Obstetrics, Medical University of Lodz, I Clinic of Gynecology and Gynecological Oncology (Lodz, Poland)

Google Scholar citation report
Citations : 61

Onkologia i Radioterapia received 61 citations as per Google Scholar report

Flyer image
Onkologia i Radioterapia peer review process verified at publons
Flyer image
Indexed In
  • Scimago
  • SCOPUS
  • MIAR
  • Euro Pub
  • Google Scholar
  • Medical Project Poland
  • PUBMED
  • Cancer Index
  • Gdansk University of Technology, Ministry Points 20
View More